Skip to main content
. 2023 Jul 22;21:218. doi: 10.1186/s12957-023-03112-8

Table 1.

Tumor characteristics and perioperative outcomes of MIBC patients undergoing radical cystectomy with a neobladder via the Studer and Y-pouch techniques

Characteristics Studer neobladder (n = 54) Y-pouch neobladder (n = 36) Total (n = 90) P value
Age, mean (± SD) 62.5 (± 10.7) 62.7 (± 11.9) 62.6 (± 11) 0.957
Gender, n (%)
 Male 54 (100) 28 (77.8) 82 (91.1) 0.021
 Female 0 (0) 8 (22.2) 8 (8.9)
Presentation
 Gross hematuria 46 (85.2) 36 (100) 82 (91.1) 0.406
 Microscopic hematuria 4 (7.4) 0 (0) 4 (4.4)
 No hematuria 4 (7.4) 0 (0) 4 (4.4)
Time to radical cystectomy (days)
 Median (IQR) 53 (18.5, 78) 69 (63.2, 109.5) 65 (42, 92) 0.05
pT stage, n (%)
 2 40 (74) 28 (77.8) 68 (75.5) 0.199
 3 12 (22.2) 2 (5.6) 14 (15.6)
 4 2 (3.7) 6 (16.7) 8 (8.9)
pN stage, n (%)
 0 48 (88.9) 32 (88.9) 80 (88.9) 0.573
 1 6 (11.1) 2 (5.6) 8 (8.9)
 2 0 (0) 2 (5.6) 2 (2.2)
Grading
 Low grade 2 (3.7) 0 (0) 2 (2.2)
 High grade 52 (96.3) 36 (100) 88 (97.8)
BMI
 Mean (± SD) 23.2 (± 2.8) 22.4 (± 2.7) 22.9 (± 2.8) 0.398
 Baseline Cr (mg/dL) 1.02 (± 0.6) 1.00 (± 0.7) 1.01 (± 0.6) 0.23
Operative time
 Median (IQR) 290 (242.5, 350) 300 (271.2, 335) 290 (255, 340) 0.826
Cystectomy time
 Median (IQR) 140 (120, 150) 130 (120, 157.5) 140 (120, 150) 0.797
Neobladder time
 Median (IQR) 150 (132.5, 200) 155 (150, 185) 155 (145, 200) 0.78
Blood loss (mL)
 Median (IQR) 1300 (1000, 1650) 1000 (800, 2000) 1200(1000,1700) 0.149
Postoperative chemotherapy 0.166
 No 8 (14.8) 12 (33.3) 20 (22.2)
 Yes 46 (85.2) 24 (66.7) 70 (77.8)
Clean intermittent catheterization 0.064
 Yes 16 (29.6) 2 (5.6) 18 (20)
 No 38 (70.4) 34 (94.4) 72 (80)
Cystostomy < 0.001
 No 0 (0) 34 (94.4) 34 (37.8)
 Yes 54 (100) 2 (5.6) 56 (62.2)
Catheterization days < 0.001
 Median (IQR) 21 (21, 21) 13.5 (10.2, 14) 21 (14, 21)

IQR interquartile range, BMI body mass index